Nantahala Capital Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.29M | Sell |
295,089
-17,005
| -5% | -$189K | 0.13% | 93 |
|
|
2025
Q1 | $3.84M | Sell |
312,094
-249,979
| -44% | -$3.07M | 0.15% | 74 |
|
|
2024
Q4 | $6.29M | Sell |
562,073
-45,817
| -8% | -$513K | 0.27% | 58 |
|
|
2024
Q3 | $4.24M | Sell |
607,890
-8,933
| -1% | -$62.3K | 0.21% | 67 |
|
|
2024
Q2 | $4.66M | Sell |
616,823
-161,437
| -21% | -$1.22M | 0.27% | 54 |
|
|
2024
Q1 | $10.3M | Sell |
778,260
-395,417
| -34% | -$5.22M | 0.59% | 28 |
|
|
2023
Q4 | $12.1M | Sell |
1,173,677
-46,238
| -4% | -$477K | 0.72% | 22 |
|
|
2023
Q3 | $11.9M | Buy |
1,219,915
+795,065
| +187% | +$7.74M | 1.01% | 15 |
|
|
2023
Q2 | $1.91M | Sell |
424,850
-1,075
| -0.3% | -$4.83K | 0.18% | 66 |
|
|
2023
Q1 | $1.98M | Sell |
425,925
-7,657
| -2% | -$35.5K | 0.15% | 65 |
|
|
2022
Q4 | $646K | Sell |
433,582
-9,920
| -2% | -$14.8K | 0.04% | 81 |
|
|
2022
Q3 | $1.66M | Sell |
443,502
-34,936
| -7% | -$131K | 0.11% | 65 |
|
|
2022
Q2 | $2.37M | Sell |
478,438
-6,865
| -1% | -$34K | 0.12% | 63 |
|
|
2022
Q1 | $3.98M | Buy |
485,303
+179,397
| +59% | +$1.47M | 0.18% | 57 |
|
|
2021
Q4 | $3.08M | Buy |
305,906
+164,265
| +116% | +$1.66M | 0.11% | 71 |
|
|
2021
Q3 | $2.25M | Sell |
141,641
-5,763
| -4% | -$91.3K | 0.07% | 80 |
|
|
2021
Q2 | $3.51M | Buy |
+147,404
| New | +$3.51M | 0.1% | 79 |
|